The latter also identified some differentially expressed miRNAs; further enrichment analysis indicated that the key regulatory miRNAs, genes and pathways in Yang syndrome were hsa-miR-93-5p and -320b, enabled homologs, metabolic pathways, and mitogen-activated protein kinase signaling pathways, respectively, while those in Yin syndrome were hsa-miR-424-5p and -106b-5p, CNOT4, hepatitis B and pathways in cancer, respectively. Here, WNK2 is linked to cancer.